US Patent Family Members and Approved Drugs for Netherlands Patent: 300211
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Netherlands Patent: NL300211
| US Patent Number | Estimated Patent Expiration | Generic Name | US Applicant | US Tradename |
|---|---|---|---|---|
| ⤷ Get Started Free | 2013-08-20 | insulin aspart protamine and insulin aspart | Novo Nordisk Inc. | NOVOLOG MIX 70/30 |
| ⤷ Get Started Free | 2013-08-20 | insulin aspart protamine and insulin aspart | Novo Nordisk Inc. | NOVOLOG MIX 50/50 |
| ⤷ Get Started Free | 2013-06-21 | insulin aspart protamine and insulin aspart | Novo Nordisk Inc. | NOVOLOG MIX 70/30 |
| >US Patent Number | >Estimated Patent Expiration | >Generic Name | >US Applicant | >US Tradename |
